chrisvoncsefalvay/vaers-outcomes huggingface dataset:
Narrative:  Chief Complaint: 73 yr old male c/o being dizzy 30 mins after Covid-19 booster, BP 180/110 and EKG changes suggestive of inferior-lateral changes. Code blue initiated after Pt at facility d/t hypertensive event -- leading Pt to Hospitalization where evaluated for cardiac causes. Code Blue Note: "FOCUSED HPI: 73 year old male patient with h/o of HTN, DM, who today had his Moderna COVID-19 booster shot, then 30 mins later felt dizzy while pick up meds in Pharmacy. A code blue was called. When code team arrived he was found to have a BP - 189/110 mmHg, HR - 64/min, T-97.9 and EKG showed a SR with interior ischemic ST/Tw changes. On further questioning he reported some mild sob, HA and that he was being w/u by a Cardiologist for a heart condition. A repeat BP was 200 mm/Hg. He was placed on NC O2, PIID placed, ASA 81 mg x 4 given and 911 called."
3/1/2023  That night I began to have a scratchy, dry cough. The next day, I was really bad that morning.  In addition to the scratchy dry cough, I was very weak all over and had a headache, nasal drainage, chest and abdominal pain from coughing so hard. I was so weak, I had to stay in bed all day. I self-medicated that night with Robitussin DM, Alka-Seltzer Cold and Flu tablets, Cold gel caps and had strong ginger tea.  It felt like I had the flu. 3/3/23 when I woke up, I felt like I had taken too much medication and felt really bad. I had a bad headache and groggy.  I had a temperature of around 100 degrees.  At dinner, I noticed my taste buds had gone, no ability to taste anything.  I took an at home COVID test and it was positive.  I tried to find an Urgent Care that night and was unable to find a place to go to or someone to talk to. I reached an online conference with MD live. She told me I  needed to get on Paxlovid.  I went to the Emergency Room and was prescribed Paxlovid. I started on the Paxlovid on 3/4/23 for five days.  I gradually got better and by the end of the five days, I felt a whole lot better and felt like it was working.  I tested around 3/13/23 and tested negative for COVID.  I have not fully recovered.  I have a little bit of residual cough and sinus issues.
No immediate reactions after vaccine besides headache and fatigue, day 4 Feb 2nd a small red circle appeared on left chest which grew in dimension to almost 2 cm. Patch was red scaly with raised edges and itchy. 14 days later small flat oval spots appeared on stomach and back. Itchy red scaly. By Feb 18, I stared to get concerned and took pictures. I recorded 62 spots on my trunk. These continued to grow, itch, spread across my torso. Some are small red spots and others are flat oval scaly shaped. Itch more with exercise or after a shower.  By March 4th, I went to my pcp. With out a throughout examine or listening to my time line she just said hives and gave me prednisone. The spots continue to grow but are seeming to fade in color slightly. I started taking acyclovir for a unrelated fever blister as well. I believe it is Pityriasis rosea given the symptoms ans timeline but I am concerned it may be related to either a case of covid or from receiving the vaccine
1/18/21 vaccinated, 1/19/21 woke up with itching to bilateral hands at 09:00 am. Woke up this am with more spots to right elbow and right chest wall. Pt. denies taking medication for it.
Brachial Clest cyst; Feeling tired the next day; Swelling in neck; This spontaneous case was reported by a consumer and describes the occurrence of SWELLING (Swelling in neck), BRANCHIAL CYST (Brachial Clest cyst) and FATIGUE (Feeling tired the next day) in a 21-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     No medical history was reported.    On 14-Apr-2021, the patient received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) dosage was changed to 1 dosage form. On an unknown date, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 14-Apr-2021, the patient experienced SWELLING (Swelling in neck). On 15-Apr-2021, the patient experienced FATIGUE (Feeling tired the next day). On an unknown date, the patient experienced BRANCHIAL CYST (Brachial Clest cyst). At the time of the report, SWELLING (Swelling in neck) and BRANCHIAL CYST (Brachial Clest cyst) outcome was unknown and FATIGUE (Feeling tired the next day) had resolved. Not Provided          Concomitant product include trilostrintec. No treatment was reported. Action taken in response to mRNA-1273 was not applicable.
Left breast has been sore; This spontaneous case was reported by a consumer and describes the occurrence of BREAST PAIN (Left breast has been sore) in a 61-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 026A21A) for COVID-19 vaccination.     No Medical History information was reported.    On 09-Mar-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On an unknown date, the patient experienced BREAST PAIN (Left breast has been sore). At the time of the report, BREAST PAIN (Left breast has been sore) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.       No concomitant medications reported by reporter. Treatment medication not reported.
Information has been received from a 62 year old female with no known allergies who on 08-JUN-2008 was vaccinated with ZOSTAVAX (lot no. not reported) via injection. Route and site of injection were not reported. Concomitant therapy included lisinopril (manufacturer unknown), SYNTROID, metformin and "Nadalol". On 10-JUN-2008 the patient developed oval shaped red bump at the injection site which felt hard to touch after vaccination. The patient's oval shaped red bump at the injection site persisted. The patient did not seek medical attention. Additional information has been requested.
Patient was seen in ER on 3/27/03 for AC cellulitis and in the clinic for ER follow up on 3/28/03 and 3/31/03. AC cellulitis.
Due to fall, head, legs, knees, back, face, nose, eye, ear, arms, hands injured. Emergency 11/17/07. Also 12/12/07.
Headache, Myalgia,  1/31 Started with chills and dry cough Sunday evening and still present Narrative:
redness in face an neck/chest. Mildly swollen/red eyes.  Developed within 15 minutes.  Improved with 50mg benadryl.  Stayed an additional 30 minutes after benadryl and symptoms continued to improve.
Approximately 25 minutes after injection, patient reported a scratchy throat, headache, bilateral arm tingling, cold sensation, difficulty swallowing.  MD at chairside, given Benadryl and Tylenol orally.  Patient continued to have cold sensation, chilling and difficulty swallowing without water.  MD ordered an additional dose of oral Benadryl.  After approximately 2-3 hours of observation, patient was discharged home with spouse in no apparent distress.
Information has been received regarding a case in litigation concerning a male child who was injected with vaccinations containing the toxic mercury based preservative thimerosal from 4/99 through at least 10/00. The alleged result of these vaccinations is that the patient suffers from and in the future will continue to suffer the toxic neurological effects of mercury poisoning. Immunization information reported that the patient was vaccinated with hepatitis B vaccine recombinant (yeast) (lot numbers not reported) on 6/18/99 and approximately 12/16/99. Other immunizations included hepatitis B vaccine, recombinant (ENGERIX B)(lot 3ENG2712A2) on 4/19/99; diphtheria toxoid (+) pertussis vaccine (+) tetanus toxoid and HIB conjugate vaccine on 6/18/99; diphtheria toxoid (+) haemophilus B conjugate vaccine (+) pertussis vaccine (+) tetanus toxoid (TETRAMUNE VACCINE) on 8/17/99; diphtheria toxoid (+) pertussis vaccine (+) tetanus toxoid and HIB conjugate vaccine on 10/18/1999; HIB conjugate vaccine on 4/18/00; and diphtheria toxoid (+) pertussis vaccine (+) tetanus toxoid on 10/18/00. Upon internal review, mercury poisoning and neurological disorder were considered to be other important medical events (OMIC). No further information is available.
Sore / achy; Feverish; Chills; red and tender swollen injection site; red and tender swollen injection site; red and tender swollen injection site; Lightheaded; swollen and tender armpit glands,; Elevated heart rate; swollen and tender armpit glands; This is a spontaneous report from a contactable consumer, the patient. A 26-year-old male patient received his first dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE, Solution for injection, Lot number: er8735) via an unspecified route of administration on 26Apr2021(at the age of 26 years old) as a single dose, for COVID-19 immunisation. Medical history included COVID-19 on an unknown date. Concomitant medications were not reported. The patient reported that his past drug history included dairy (unspecified). Prior to the vaccination, the patient was diagnosed with COVID-19. Since the vaccination, the patient had not been tested positive for COVID-19. The patient experienced sore / achy, feverish, chills, red and tender swollen injection site, lightheaded, swollen and tender armpit glands and elevated heart rate on 26Apr2021. The patient did not receive any treatment for the events. The clinical outcome of the events sore / achy, feverish, chills, red and tender swollen injection site, lightheaded, swollen and tender armpit glands, elevated heart rate were resolving at the time of this report.   No follow-up attempts are needed. No further information is expected.  Amendment: This follow-up report is being submitted to amend previously reported information: Patient email address added, medical history added (known allergies: dairy), treatment received was ticked as No and updated narrative.
Vaccine was given on a Wednesday. On Thursday left eyebrow felt itchy. By Friday I noticed a few hairs had fallen. By Saturday half of my eyebrow was gone. I also noticed on Saturday that I had some skin discoloration on my right hand. Two weeks later, while shaving I noticed that a patch of facial hair had stopped growing. Since then loss of facial hair has spread and as of right now, my eyebrow hair has not grown back, and facial hair has not grown back and is spreading.
Itching and hives over upper body 40-60 min after YF vaccine; call to UC and advised to given child Benadryl - this was taken at 1800 and father reports itching resolved and hives nearly gone at 2300; next day symptoms resolved and child went to school.
Information has been received from a 63 year old female patient concerning her grandson, who on 13-JUN-2008 was exposed to his grandmother who was vaccinated with ZOSTAVAX on 06-JUN-2008. On 23-JUN-2008, he developed atypical chicken pox. This is one of several reports from the same source. Additional information has been requested.
11/05 began blistering rash wrist, next day DX with shingles.
Mild but constant tinnitus not affecting hearing.; This is a spontaneous report from a contactable consumer, the patient. A 64-year-old non-pregnant female patient received the first dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: EN6204) via an unspecified route of administration in the right arm on an unknown date in Mar2021 at 17:30 (at the age of 64-year-old) and second dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: ER8733) via an unspecified route of administration in the right arm on 11Apr2021 at 15:00 (at the age of 64-year-old) as a single dose for COVID-19 immunisation. The patient did not have any relevant medical history. Prior to the vaccination, the patient was not diagnosed with COVID-19. The patient did not receive any other vaccines within four weeks prior to the vaccination. The patient did not receive any medication within two weeks of vaccination. On an unknown date in Apr2021, the patient experienced mild but constant tinnitus which was not affecting hearing. The adverse event did not result in doctor or other healthcare professional office/clinic visit and emergency room/department or urgent care. Therapeutic measures were not taken as a result of the reported event. Since the vaccination, the patient had not been tested for COVID-19. The clinical outcome of the event mild but constant tinnitus was not recovered at the time of this report.    No follow-up attempts are needed. No further information is expected.
This spontaneous case was reported by a pharmacist and describes the occurrence of POOR QUALITY PRODUCT ADMINISTERED (doses administered after excursion), PRODUCT TEMPERATURE EXCURSION ISSUE (Prior to knowing that the vaccines which underwent a temperature excursion in the freezer were viable store) and NO ADVERSE EVENT (No adverse event) in a 27-year-old female patient who received mRNA-1273 BIVALENT .222 (MODERNA COVID-19 VACCINE, BIVALENT (ORIGINAL AND OMICRON BA.4/BA.5)) (batch no. AS7147B) for COVID-19 prophylaxis.          F   No concomitant medications were reported.  The pharmacist reported that, temperature excursion occurred several days ago in the freezer. Multiple patients received vaccine from vaccine that underwent a temperature excursion in the Freezer, and they just found out about the excursion in an audit.   No adverse event reported for the patient.  No treatment medications were reported.
he had a flare up of urticaria; This is a spontaneous report from a contactable consumer (patient). A male patient of an unspecified age received first dose of bnt162b2 (PFIZER-BIONTECH COVID-19 VACCINE, Solution for injection, Batch/Lot number was not reported) via an unspecified route of administration on 25Apr2021 as dose 1, single for COVID-19 immunization. The patient medical history included idiopathic chronic urticaria and takes cyclosporine for flare ups. The patient concomitant medications were not reported. After the first dose of the Pfizer Covid 19 vaccine on 25Apr2021 he had a flare up of urticaria. It happened about 4-5 days after the first dose of the vaccine. He had his second dose this past Friday, 21May2021. The patient was getting a little bit of urticaria back. The outcome of the event was unknown.  Follow-up attempts not completed; information about lot/batch number cannot be obtained. No further information expected.
Femoral Bloodclot in groin, leg swelling, leg turned blue followed by intense pain. Patient went to ER in July 2021 (3 1/2 hours), Hospitalized (2 1/2 days)
Patient came with mother, after completing form online and making an appointment. I printed the completed form; had the mother go over it and sign it. Obtained copy of mother's ID and insurance card. Gave mother patient information sheet. Did counseling and administered vaccination to the daughter. When processing the claim, insurance rejected it for invalid DOB. I called insurance and was told the DOB for patient is 01/08/2009. This is not what the mother filled-out on the consent form.
24 hours after shot developed a fever of 100.8 which lasted for 36 hours.; Extreme dizziness/vertigo approximately 2.5 hours after shot w/ impaired vision; Extreme dizziness/vertigo approximately 2.5 hours after shot w/ impaired vision.; Extreme dizziness/vertigo approximately 2.5 hours after shot w/ impaired vision.; This is a spontaneous report from a contactable consumer, the patient. A 55-year-old non-pregnant female patient received the first dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: UNKNOWN) via an unspecified route of administration in the right arm on 23Apr2021 at 16:30 (at the age of 55-years-old) as a single dose for COVID-19 immunisation. The patient had no relevant medical history. The had no known allergies. Prior to the vaccination, the patient was not diagnosed with COVID-19. The patient did not receive any other vaccines within four weeks prior to the vaccination. The patient did not receive any medications within two weeks of vaccination. On 23Apr2021 at 18:45, approximately 2.5 hours after the shot, the patient experienced extreme dizziness/vertigo with impaired vision. It was made better by closing the eyes and was lessened after slept for 6 hours. But it came back in waves for the next 48 hours. On 24Apr2021, 24 hours after the shot, the patient experienced a fever of 100.8 which lasted for 36 hours. On the same day, the patient underwent body temperature test and the result was 100.8 (unknown units). The adverse events did not result in doctor or other healthcare professional office/clinic visit and emergency room/department or urgent care. Therapeutic measures were not taken as a result of the reported events. Since the vaccination, the patient had not been tested for COVID-19. The clinical outcome of the event fever of 100.8 was resolved on an unspecified date in Apr2021; while the clinical outcome of the events extreme dizziness, vertigo and impaired vision were resolving at the time of this report.   No follow-up attempts are required; information about lot/batch number cannot be obtained. No further information is expected.
Initial tongue swelling; Extreme muscle cramping; Terrible joint pain; Extremely exhausted; Shaking; This is a spontaneous report from a contactable consumer (patient). A 54-year-old non-pregnant female patient patient received BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE, Solution for injection, Batch/Lot Number: unknown, Expiry date: unknown, age at vaccination 54 years) via an unspecified route of administration on 18Mar2021 09:00 on Arm Left as dose 1, single for covid-19 immunisation administered at Pharmacy or Drug Store. The medical history includes IC Hashimoto's IBS. Allergies to food was Latex and shellfish. Concomitant medications within 2 weeks were not reported. The patient did not receive any other vaccines or medication within 4 weeks prior to the COVID vaccine. Prior to vaccination, was the patient was not diagnosed with COVID. Since the vaccination, the patient has been tested for COVID-19. On 18Mar2021 09:45 the patient reported, Initial tongue swelling. Extreme muscle cramping, she was out of  rooms and extremities. Terrible joint pain as if she had room Atari arthritis. Extremely exhausted. Shaking. Been to urgent care once and taken by ambulance to ER once. The adverse event resulted in Doctor or other healthcare professional office/clinic visit, Emergency room/department or urgent care. Treatment received for the adverse event was Benadryl tongue swelling. Muscle relaxer. Covid prior vaccination was No. Covid tested post vaccination was Yes. The patient underwent lab tests and procedures which included Nasal Swab test result negative on unspecified date. The outcome of the events was not recovered.  Information on the lot/batch number has been requested.
Narrative: Incidental COVID-19 positive test on admission 5/7/21, asymptomatic.
Patient received vaccine and approximately 5 -7 minutes later felt faint.  Patient felt cold and clammy and was pale. Patient blood pressure and temperature were normal.  Patient sat and rested for approximately 20 minutes after symptoms started  and felt better.  No longer sweating and color returned.
Immediately  after vaccination patient felt experienced stomach upset, then tingling around the mouth. No respiratory issues, but had facial flushing nd mild redness and swelling around the eyes with some itching. Benedryl capsule PO given and responded with in 15 minutes. Driven home by husband and advised to seek ER RX  if needed. Advised not to seek 2nd does of vaccine.
Patient was diagnosed with COVID on October 13. came to the ER with respiratory distress from nursing home on November 4th.  Signs and symptoms:  shortness of breath Pulse ox on the scene was 70% on oxygen.  Treatment: 100% oxygen.(intubation)
pt recv vax 20SEP95 & 20APR96 pt exp h/a on/off tiredness & dec appetite;28APR96 devel rash consistent w/herpes zoster w/neuralgia involving C-7/C-8/T-1 dermatones;shingles were described as multiple vesicular papules w/tenderness @ site
inadvertently given expired product with no reported adverse event; inadvertently given expired product with no reported adverse event; Initial information received on 10-Oct-2022 regarding an unsolicited valid  non-serious case received from a other health professional.  This case is linked to cases 2022SA418835(CLUSTER), 2022SA419132(CLUSTER) and 2022SA418873(CLUSTER).  This case involves a 13 years old female patient who was inadvertently given expired product with no reported adverse event ,after receiving vaccine INFLUENZA QUADRIVAL A-B VACCINE [FLUZONE QIV].  The patient's past medical history, medical treatment(s), vaccination(s) and family history were not provided.   On 07-Oct-2022, the patient received a total dose of suspect INFLUENZA QUADRIVAL A-B VACCINE (lot UT7378MA and expiration date: 30-Jun-2024) at a dose of 0.5ml once via intramuscular route in the left deltoid for immunization.  On 07-Oct-2022(latency: same day), the patient was inadvertently given expired product with no reported adverse event (expired product administered) (accidental exposure to product) following the administration.  Action taken:not applicable.  It was not reported if the patient received a corrective treatment for the events.   Outcome: unknown for both events   This suspected adverse reaction report is submitted and classified as a medication error solely and exclusively to ensure the marketing authorization holder's compliance with the requirements set out in the Directive 2001/83/EC and Module VI of the Good Pharmacovigilance Practices. The classification as a medical error is in no way intended, nor should it be interpreted or construed as an allegation or claim made by the marketing authorization holder that any third party has contributed to or is to be held liable for the occurrence of this medication error.
Tonic-Clonic Seizure lasting 3 min. face went pale. Treatment: lowered new hire to ground on left side supported head with pillow and monitored breathing, vital signs taken after seizure 125/68. 911 called at beginning of seizure paramedic arrived and transported new hire to Medical Center.
Eyes rolled back, seizure, layed patient down, seizure lasted about 15 seconds, checked BP, pulse, EMS arrived - patient was alert but pale 1st BP 146/84 - 2nd BP 119/100 - pulse 75 both times. (Patient says he is afraid of needles).
Given ADACEL & flu shot 9/2/11 in the morning. Came back at 5:00 PM same day with rash. Noted papular, urticarial rash on ext. Rx with adrenaline shot & ATARAX. Went to ER Sept. 3 with same urticaria & tx with shot & steroid.